Lei Yin
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research
- Immunology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Paul L. NguyenStuart R. LipsitzXiangmei GuJim C. HuToni K. ChoueiriKaren E. HoffmanWesley W. ChoiKonstantinos Tryfonidis
- Topics
- Cancer Immunotherapy and Biomarkers (10 papers)Lung Cancer Treatments and Mutations (6 papers)Bladder and Urothelial Cancer Treatments (5 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Lei Yin
35 papers receiving 813 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 468
- Pulmonary and Respiratory Medicine 406
- Cancer Research 128
- Immunology 115
- Radiology, Nuclear Medicine and Imaging 88
Countries citing papers authored by Lei Yin
This map shows the geographic impact of Lei Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Yin more than expected).
Fields of papers citing papers by Lei Yin
This network shows the impact of papers produced by Lei Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Yin. The network helps show where Lei Yin may publish in the future.
Co-authorship network of co-authors of Lei Yin
This figure shows the co-authorship network connecting the top 25 collaborators of Lei Yin. A scholar is included among the top collaborators of Lei Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Yin. Lei Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 2 | |
| 10 | 2 | |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 88 | |
| 14 | 11 | |
| 15 | Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 studybreakdown → | 279 |
| 16 | 5 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 0 | |
| 20 | 230 |
About Lei Yin
Lei Yin is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 833 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). The work is most often cited by research in Oncology (468 citations), Pulmonary and Respiratory Medicine (406 citations) and Cancer Research (128 citations). Lei Yin has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Paul L. Nguyen, Stuart R. Lipsitz, Xiangmei Gu, Jim C. Hu, Toni K. Choueiri, Karen E. Hoffman, Wesley W. Choi, Konstantinos Tryfonidis, Theodoros Foukakis and Peter Schmid. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.